The pathogenetic significance of intestinal Candida colonization.
Crandall
Marjorie
M
D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000472:pathogenicity*; D002177:Candidiasis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D018849:Controlled Clinical Trials as Topic; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D006967:Hypersensitivity / Q000382:microbiology; D007073:Immunoglobulin E; D009761:Nystatin / Q000627:therapeutic use; D015203:Reproducibility of Results; D012107:Research Design; D013577:Syndrome
D000935:Antifungal Agents; D009761:Nystatin; D007073:Immunoglobulin E